At a glance
- Originator Aventis
- Class Antidepressants; Small molecules
- Mechanism of Action Adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 14 Aug 1996 Discontinued-III for Depression in European Union (PO)